The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, cilt.38, sa.2, ss.299-308, 2022 (SCI-Expanded)